STOCK TITAN

TELA Bio to Participate in Canaccord Genuity’s 41st Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

MALVERN, Pa., Aug. 03, 2021 – TELA Bio, Inc. (NASDAQ: TELA) has announced its participation in Canaccord Genuity’s 41st Annual Growth Conference. Management will present on August 12, 2021, at 2:00 PM EDT. The company specializes in innovative tissue reinforcement materials aimed at enhancing soft tissue reconstruction outcomes. TELA’s OviTex® and OviTex PRS products are designed to improve hernia repair and abdominal wall reconstruction processes while minimizing reliance on synthetic materials.

Positive
  • None.
Negative
  • None.

MALVERN, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company will participate in Canaccord Genuity’s 41st Annual Growth Conference.

TELA Bio's management is scheduled to present at Canaccord Genuity’s 41st Annual Growth Conference on Thursday, August 12, 2021 at 2:00 PM EDT. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The Company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com


FAQ

When is TELA Bio's presentation at Canaccord Genuity’s 41st Annual Growth Conference?

TELA Bio's presentation is scheduled for August 12, 2021, at 2:00 PM EDT.

What is the focus of TELA Bio's products?

TELA Bio focuses on innovative tissue reinforcement materials for soft tissue reconstruction.

Where can I watch TELA Bio's conference presentation?

The presentation can be accessed live and archived at ir.telabio.com.

What are TELA Bio's main products?

TELA's main products include OviTex® and OviTex PRS Reinforced Tissue Matrix.

What is TELA Bio's stock symbol?

The stock symbol for TELA Bio is TELA, traded on NASDAQ.

TELA Bio, Inc.

NASDAQ:TELA

TELA Rankings

TELA Latest News

TELA Stock Data

112.65M
33.31M
7.32%
51.7%
0.85%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MALVERN